Photo: RNZ / Nate McKinnon
Pharmaceutical and pet supplies company Ebos has reported a lower full year profit as sales fell because of the end of a key wholesale contract.
Key numbers for the 12 months ended June compared with a year ago - in Australian dollars:
- Net profit $215m vs $272m
- Revenue $12.3b vs $13.2b
- Operating earnings $556m vs $606m
- Forecast underlying earnings 2026 $615m-$635m
- Final dividend 61.5 NZ cents per share
The company's results reflected the end of the $2 billion contract to supply the Chemist Warehouse Australia, but the company said underlying revenue and earnings had increased, with the overall result in line with its earnings guidance.
Chief executive Adam Hall said the company remained a leading pharmaceuticals company through its TerryWhite Chemmart network in Australia, as well as being significant in supplying hospital medicines on both sides of the Tasman.
Healthcare revenue was down overall about 8 percent, but leaving aside the end of the Chemist Warehouse contract revenue was up close to 12 percent.
The petcare business, which includes a stake in the Animates chain in New Zealand and leading petfood brands Black Hawk and Vitapet, increased revenue by 16 percent .
"In FY25 (financial year 2025), we reinforced our leadership positions across the healthcare and animal care sectors.
"Ebos has delivered against its near-term strategic priorities, delivering profitable growth with a strong focus on maintaining our ... margins."
The company said it expected the five businesses it acquired last year, including pet food and medical technology companies, to contribute about $330m in earnings over a year, and has also been spending on upgrading and developing its warehousing facilities.
"Near-term macro pressures include a competitive wholesale pharmacy environment, soft hospital capital spend and subdued consumer sentiment impacting discretionary pet categories," the company said in a commentary.
"Our portfolio is well positioned for long-term growth with continued positive healthcare and animal care industry trends supporting the resilience of our businesses."
